These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeted Therapy for Metastatic Renal Cell Carcinoma. Afriansyah A; Hamid AR; Mochtar CA; Umbas R Acta Med Indones; 2016 Oct; 48(4):335-347. PubMed ID: 28143997 [TBL] [Abstract][Full Text] [Related]
3. Signaling inhibitors in metastatic renal cell carcinoma. Escudier B Cancer J; 2008; 14(5):325-9. PubMed ID: 18836338 [TBL] [Abstract][Full Text] [Related]
4. [Novelties in the treatment for advanced renal-cell cancer]. Maráz A Orv Hetil; 2011 Apr; 152(17):655-62. PubMed ID: 21464023 [TBL] [Abstract][Full Text] [Related]
5. Targeted therapies in metastatic renal cancer in 2009. Bastien L; Culine S; Paule B; Ledbai S; Patard JJ; de la Taille A BJU Int; 2009 May; 103(10):1334-42. PubMed ID: 19338565 [TBL] [Abstract][Full Text] [Related]
6. Pazopanib as second-line treatment after sunitinib or bevacizumab in patients with advanced renal cell carcinoma: a Sarah Cannon Oncology Research Consortium Phase II Trial. Hainsworth JD; Rubin MS; Arrowsmith ER; Khatcheressian J; Crane EJ; Franco LA Clin Genitourin Cancer; 2013 Sep; 11(3):270-5. PubMed ID: 23665131 [TBL] [Abstract][Full Text] [Related]
7. Sarcomatoid dedifferentiation in metastatic clear cell renal cell carcinoma and outcome on treatment with anti-vascular endothelial growth factor receptor tyrosine kinase inhibitors: a retrospective analysis. Beuselinck B; Lerut E; Wolter P; Dumez H; Berkers J; Van Poppel H; Joniau S; Oyen R; De Wever L; Strijbos M; Paridaens R; Schöffski P Clin Genitourin Cancer; 2014 Oct; 12(5):e205-14. PubMed ID: 24861951 [TBL] [Abstract][Full Text] [Related]
10. Treatment patterns: targeted therapies indicated for first-line management of metastatic renal cell carcinoma in a real-world setting. Hess G; Borker R; Fonseca E Clin Genitourin Cancer; 2013 Jun; 11(2):161-7. PubMed ID: 23267717 [TBL] [Abstract][Full Text] [Related]
11. Tolerability of first-line therapy for metastatic renal cell carcinoma. Porta C; Szczylik C Cancer Treat Rev; 2009 May; 35(3):297-307. PubMed ID: 19249157 [TBL] [Abstract][Full Text] [Related]
12. [Medical treatment of renal cell carcinoma]. Guy L; Bay JO; Bastide C; Mahammedi H; Bruyere F; Karsenty G Prog Urol; 2013 Nov; 23(15):1225-37. PubMed ID: 24183081 [TBL] [Abstract][Full Text] [Related]
13. [Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]. Miller K; Bergmann L; Gschwend J; Keilholz U Aktuelle Urol; 2011 Jul; 42(4):242-6. PubMed ID: 21720974 [TBL] [Abstract][Full Text] [Related]
14. A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma. Alasker A; Meskawi M; Sun M; Ismail S; Hanna N; Hansen J; Tian Z; Bianchi M; Perrotte P; Karakiewicz PI Cancer Treat Rev; 2013 Jun; 39(4):388-401. PubMed ID: 23317510 [TBL] [Abstract][Full Text] [Related]
15. Pazopanib outscores sunitinib on tolerability. Cancer Discov; 2014 Jan; 4(1):OF8. PubMed ID: 24402960 [TBL] [Abstract][Full Text] [Related]
16. Management of metastatic renal cell carcinoma progressed after sunitinib or another antiangiogenic treatment. Iacovelli R; Palazzo A; Trenta P; Mezi S; Pellegrino D; Naso G; Cortesi E Am J Clin Oncol; 2014 Dec; 37(6):611-5. PubMed ID: 23388560 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium. Vickers MM; Al-Harbi H; Choueiri TK; Kollmannsberger C; North S; MacKenzie M; Knox JJ; Rini BI; Heng DY Clin Genitourin Cancer; 2013 Sep; 11(3):311-5. PubMed ID: 23684422 [TBL] [Abstract][Full Text] [Related]
18. [Systemic therapy of metastatic renal cell carcinoma]. Maute L; Bergmann L Dtsch Med Wochenschr; 2016 Apr; 141(7):466-9. PubMed ID: 27031198 [TBL] [Abstract][Full Text] [Related]
19. First-line treatment of metastatic renal cell carcinoma after COMPARZ and PISCES. Schmidinger M; Wittes J Curr Opin Urol; 2015 Sep; 25(5):395-401. PubMed ID: 26148069 [TBL] [Abstract][Full Text] [Related]
20. New therapeutic approaches in the management of metastatic renal cell carcinoma. Gkialas IK; Papadopoulos G J BUON; 2009; 14(3):399-404. PubMed ID: 19810129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]